PreveCeutical Medical Inc (CNSX:PREV – Get Free Report) insider Michael Moeller purchased 650,000 shares of the company’s stock in a transaction dated Friday, March 14th. The stock was purchased at an average price of $0.03 per share, with a total value of $16,250.00.
PreveCeutical Medical Stock Performance
About PreveCeutical Medical
PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity.
Featured Stories
- Five stocks we like better than PreveCeutical Medical
- Stock Market Upgrades: What Are They?
- How to Build the Ultimate Everything ETF Portfolio
- Are Penny Stocks a Good Fit for Your Portfolio?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What Are the FAANG Stocks and Are They Good Investments?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for PreveCeutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PreveCeutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
